$19.28▴ 1.21%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Legend Biotech Corporation - American Depositary Shares's earnings-quality signal is not available yet.
Key numbers
Recent news
Why Is Legend Biotech Stock Falling Thursday?Legend Biotech Corporation Announces Pricing of Public Offering
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- Legend Biotech (LEGN) Soars 42% on Promising Cancer Therapy Results